Review
Copyright ©The Author(s) 2021.
World J Gastrointest Oncol. Oct 15, 2021; 13(10): 1302-1316
Published online Oct 15, 2021. doi: 10.4251/wjgo.v13.i10.1302
Figure 5
Figure 5 Hepatocellular carcinoma. A: Contrast enhanced ultrasound examination in the arterial phase (15 s after the i.v. injection of contrast agent) shows a vivid heterogeneous contrast enhancement (arrows); B: In the portal phase (78 s after the injection) the hepatocellular carcinoma (HCC) is isoechoic in comparison to adjacent liver parenchyma (arrows); C: In the extended portal phase (3 min after the injection) the HCC shows a mild wash-out, being hypoechoic in comparison to adjacent liver parenchyma (arrows).